Rekah Pharmaceutical Industry Ltd.

TASE:REKA 주식 보고서

시가총액: ₪167.1m

Rekah Pharmaceutical Industry 대차 대조표 상태

재무 상태 기준 확인 4/6

Rekah Pharmaceutical Industry 의 총 주주 지분은 ₪169.2M 이고 총 부채는 ₪94.0M, 이는 부채 대 자기자본 비율을 55.6% 로 가져옵니다. 총자산과 총부채는 각각 ₪451.8M 및 ₪282.7M 입니다. Rekah Pharmaceutical Industry 의 EBIT는 ₪18.1M 이며 이자보상배율은 2.7 입니다. ₪5.4M 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

55.6%

부채 비율

₪93.97m

부채

이자 보상 비율2.7x
현금₪5.45m
주식₪169.15m
총 부채₪282.68m
총 자산₪451.83m

최근 재무 상태 업데이트

Recent updates

Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Shares Climb 30% But Its Business Is Yet to Catch Up

Jul 11
Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Shares Climb 30% But Its Business Is Yet to Catch Up

Here's Why Rekah Pharmaceutical Industry (TLV:REKA) Has A Meaningful Debt Burden

Jul 05
Here's Why Rekah Pharmaceutical Industry (TLV:REKA) Has A Meaningful Debt Burden

Here's Why Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) CEO May Not Expect A Pay Rise This Year

Dec 14
Here's Why Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) CEO May Not Expect A Pay Rise This Year

Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet

Sep 12
Rekah Pharmaceutical Industry (TLV:REKA) Has A Somewhat Strained Balance Sheet

Estimating The Fair Value Of Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Jul 19
Estimating The Fair Value Of Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Rekah Pharmaceutical Industry's (TLV:REKA) Problems Go Beyond Weak Profit

Apr 13
Rekah Pharmaceutical Industry's (TLV:REKA) Problems Go Beyond Weak Profit

We Think Rekah Pharmaceutical Industry (TLV:REKA) Is Taking Some Risk With Its Debt

May 12
We Think Rekah Pharmaceutical Industry (TLV:REKA) Is Taking Some Risk With Its Debt

Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Might Deserve Your Attention Today

Apr 09
Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Might Deserve Your Attention Today

Does Rekah Pharmaceutical Industry's (TLV:REKA) Share Price Gain of 50% Match Its Business Performance?

Mar 12
Does Rekah Pharmaceutical Industry's (TLV:REKA) Share Price Gain of 50% Match Its Business Performance?

Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Feb 19
Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Is Rekah Pharmaceutical Industry (TLV:REKA) Using Too Much Debt?

Jan 29
Is Rekah Pharmaceutical Industry (TLV:REKA) Using Too Much Debt?

Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Is An Interesting Stock

Jan 08
Here's Why I Think Rekah Pharmaceutical Industry (TLV:REKA) Is An Interesting Stock

How Is Rekah Pharmaceutical Industry's (TLV:REKA) CEO Paid Relative To Peers?

Dec 18
How Is Rekah Pharmaceutical Industry's (TLV:REKA) CEO Paid Relative To Peers?

Investors Who Bought Rekah Pharmaceutical Industry (TLV:REKA) Shares Five Years Ago Are Now Up 33%

Nov 30
Investors Who Bought Rekah Pharmaceutical Industry (TLV:REKA) Shares Five Years Ago Are Now Up 33%

재무 상태 분석

단기부채: REKA 의 단기 자산 ( ₪225.0M )이 단기 부채( ₪151.0M ).

장기 부채: REKA 의 단기 자산( ₪225.0M )이 장기 부채( ₪131.7M ).


부채 대 자본 내역 및 분석

부채 수준: REKA 의 순부채 대 자기자본 비율( 52.3% )은 높음으로 간주됩니다.

부채 감소: REKA 의 부채 대 자기자본 비율은 지난 5년간 58.6% 에서 55.6% 로 감소했습니다.

부채 범위: REKA 의 부채는 영업 현금 흐름 ( 25.7% )에 의해 잘 충당되었습니다.

이자 보장: REKA 의 부채에 대한 이자 지급EBIT( 2.7 x 적용 범위)만큼 잘 덮이지 않음입니다.


대차 대조표


건강한 기업 발견하기